US 12,109,313 B2
Soluble fiber lozenge
Feng Gao, Midlothian, VA (US); Diane L. Gee, Chesterfield, VA (US); Shuzhong Zhuang, Glen Allen, VA (US); Phillip M. Hulan, Midlothian, VA (US); William J. Burke, Nashville, TN (US); and Gerd Kobal, Sandy Hook, VA (US)
Assigned to Altria Client Services LLC, Richmond, VA (US)
Filed by Altria Client Services LLC, Richmond, VA (US)
Filed on Dec. 15, 2022, as Appl. No. 18/066,730.
Application 18/066,730 is a continuation of application No. 16/132,728, filed on Sep. 17, 2018, granted, now 11,554,099.
Application 16/132,728 is a continuation of application No. 14/505,988, filed on Oct. 3, 2014, granted, now 10,105,320, issued on Oct. 23, 2018.
Claims priority of provisional application 61/886,373, filed on Oct. 3, 2013.
Prior Publication US 2023/0121049 A1, Apr. 20, 2023
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 9/20 (2006.01); A23G 3/34 (2006.01); A23G 3/38 (2006.01); A23G 3/42 (2006.01); A61K 8/73 (2006.01); A61K 9/00 (2006.01); A61Q 11/00 (2006.01)
CPC A61K 9/2059 (2013.01) [A23G 3/0021 (2013.01); A23G 3/38 (2013.01); A23G 3/42 (2013.01); A61K 8/732 (2013.01); A61Q 11/00 (2013.01); A23V 2002/00 (2013.01); A61K 9/0056 (2013.01)] 19 Claims
 
1. A lozenge
formed from a molten mixture heated to a maximum temperature of no more than 120° C., the lozenge comprising:
soluble fibers in an amount of greater than or equal to 40 weight percent of the lozenge, the soluble fibers being non-cross-linked;
triglycerides dispersed within the soluble fibers, the triglycerides present in an amount of less than 20 weight percent;
water; and
an additive, the lozenge having a glass transition temperature of greater than 37° C.